Reconstructed MRI Images Guide Radiotherapy Treatment
|
By MedImaging International staff writers Posted on 07 Jul 2021 |
|
Image: The MRgRT treatment room at the ICR (Photo courtesy of ICR)
An artificial intelligence (AI) algorithm that reconstructs magnetic resonance imaging (MRI) images of moving tumors in seconds could optimize radiotherapy (RT) treatment, according to a new study.
Developed at The Institute of Cancer Research (ICR; London, United Kingdom), The Royal Marsden NHS Foundation Trust (London, United Kingdom), the German Cancer Research Center (DKFZ; Heidelberg, Germany), and other institutions, magnetic resonance guided radiotherapy (MRgRT) is based on a deep radial convolutional neural network (Dracula) algorithm that replicates four-dimensional (4D) MRI images, including tumors and healthy organs, from low quality images containing artifacts.
By using data on the spatial dimensions and respiratory phases of a patient's tumor and surrounding organs, Dracula can produce 4D MRI and mid-position images from scans previously considered unacceptable for MRgRT. Clinically, the MRI images reconstructed by Dracula can be used to guide a linear accelerator (Linac), thus serving as a novel platform to locate and deliver precisely targeted RT doses to tumors, minimizing the risk of affecting healthy organs. The study was published in the June 2021 issue of Radiotherapy and Oncology.
“Using an AI to rapidly reconstruct 4D MRI images of a cancer patient's anatomy lets us accurately determine the location of tumors and characterize their motion right before RT treatment,” said senior author Andreas Wetscherek, PhD, of the ICR. “It would be especially useful for cancers where we need to avoid the healthy organs around the tumor, such as pancreatic cancer, which currently limits the delivery of high doses of radiation to the tumor.”
To treat patients with tumors that move as they breathe, 4D MRI images are needed to show the 3D volume of the tumor and surrounding organs at different time points during breathing, known as a respiratory phase. By combining respiratory phases, the midposition (the average position of the tumor) is calculated, helping to accurately plan MRgRT. An alternative is to have a patient hold their breath, but this can be strenuous for the patient and makes treatment longer and more difficult.
Related Links:
The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust
German Cancer Research Center
Developed at The Institute of Cancer Research (ICR; London, United Kingdom), The Royal Marsden NHS Foundation Trust (London, United Kingdom), the German Cancer Research Center (DKFZ; Heidelberg, Germany), and other institutions, magnetic resonance guided radiotherapy (MRgRT) is based on a deep radial convolutional neural network (Dracula) algorithm that replicates four-dimensional (4D) MRI images, including tumors and healthy organs, from low quality images containing artifacts.
By using data on the spatial dimensions and respiratory phases of a patient's tumor and surrounding organs, Dracula can produce 4D MRI and mid-position images from scans previously considered unacceptable for MRgRT. Clinically, the MRI images reconstructed by Dracula can be used to guide a linear accelerator (Linac), thus serving as a novel platform to locate and deliver precisely targeted RT doses to tumors, minimizing the risk of affecting healthy organs. The study was published in the June 2021 issue of Radiotherapy and Oncology.
“Using an AI to rapidly reconstruct 4D MRI images of a cancer patient's anatomy lets us accurately determine the location of tumors and characterize their motion right before RT treatment,” said senior author Andreas Wetscherek, PhD, of the ICR. “It would be especially useful for cancers where we need to avoid the healthy organs around the tumor, such as pancreatic cancer, which currently limits the delivery of high doses of radiation to the tumor.”
To treat patients with tumors that move as they breathe, 4D MRI images are needed to show the 3D volume of the tumor and surrounding organs at different time points during breathing, known as a respiratory phase. By combining respiratory phases, the midposition (the average position of the tumor) is calculated, helping to accurately plan MRgRT. An alternative is to have a patient hold their breath, but this can be strenuous for the patient and makes treatment longer and more difficult.
Related Links:
The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust
German Cancer Research Center
X-ray Diagnostic System
FDX Visionary-A
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Ultrasonic Pocket Doppler
SD1
Multi-Use Ultrasound Table
Clinton
Latest Nuclear Medicine News
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
Channels
Radiography
view channel
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
Cardiovascular disease remains the leading cause of death in women worldwide, responsible for about nine million deaths annually. Despite this burden, symptoms and risk factors are often under-recognized... Read more
MRI
view channel
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
Ultrasound
view channel
Ultrasound Probe Images Entire Organ in 4D
Disorders of blood microcirculation can have devastating effects, contributing to heart failure, kidney failure, and chronic diseases. However, existing imaging technologies cannot visualize the full network... Read more
Disposable Ultrasound Patch Performs Better Than Existing Devices
Wearable ultrasound devices are widely used in diagnostics, rehabilitation monitoring, and telemedicine, yet most existing models rely on lead-based piezoelectric ceramics that pose health and environmental risks.... Read more
General/Advanced Imaging
view channel
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more